Desonide/Ketoconazole

地奈德/酮康唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDesonide/Ketoconazole
Drug Alias Name酮康唑+地奈德Ketoconazole and DesonideKetoconazole/Desonide地奈德酮康唑Desonide and Ketoconazole +[7] 
ClassificationSmall molecules
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsGlucocorticoid receptor agonists
TargetsLanosterol 14α-demethylaseGlucocorticoid receptor
Therapy Area/IndicationsDermatitis, Seborrheic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes DesonideKetoconazole
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBarrier Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBarrier Therapeutics
Active IndicationsN/A
Inactive IndicationsDermatitis, Seborrheic

Other Information

ATC CodeN/A
Related LinksN/A